Literature DB >> 1371464

Dysregulation of gene expression in mouse trisomy 16, an animal model of Down syndrome.

D M Holtzman1, R M Bayney, Y W Li, H Khosrovi, C N Berger, C J Epstein, W C Mobley.   

Abstract

In humans, trisomy 21 results in a specific phenotype known as Down syndrome (DS). The mechanism by which an extra copy of normal genes leads to the DS phenotype is unknown. Most studies in DS and other aneuploid organisms have shown that gene dose is proportional to gene expression. To date, most genes examined have encoded either metabolic enzymes or constitutively expressed products. In the trisomy 16 mouse, an animal model of DS, we found marked dysregulation of two developmentally regulated genes, App and Prn-p. Dysregulation varied from tissue to tissue and during development in the same tissue. We conclude that abnormal phenotypes seen in aneuploid conditions may result in part from disordered expression of developmentally regulated genes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371464      PMCID: PMC556494          DOI: 10.1002/j.1460-2075.1992.tb05094.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  46 in total

1.  Dependence of position-effect variegation in Drosophila on dose of a gene encoding an unusual zinc-finger protein.

Authors:  G Reuter; M Giarre; J Farah; J Gausz; A Spierer; P Spierer
Journal:  Nature       Date:  1990-03-15       Impact factor: 49.962

2.  Sex-specific splicing and polyadenylation of dsx pre-mRNA requires a sequence that binds specifically to tra-2 protein in vitro.

Authors:  M L Hedley; T Maniatis
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

3.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

4.  Expression of the amyloid precursor protein gene in mouse oocytes and embryos.

Authors:  S Fisher; J D Gearhart; M L Oster-Granite
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

5.  Formation of beta-amyloid protein deposits in brains of transgenic mice.

Authors:  D Quon; Y Wang; R Catalano; J M Scardina; K Murakami; B Cordell
Journal:  Nature       Date:  1991-07-18       Impact factor: 49.962

6.  Deposits of amyloid beta protein in the central nervous system of transgenic mice.

Authors:  D O Wirak; R Bayney; T V Ramabhadran; R P Fracasso; J T Hart; P E Hauer; P Hsiau; S K Pekar; G A Scangos; B D Trapp
Journal:  Science       Date:  1991-07-19       Impact factor: 47.728

7.  Expression of bovine superoxide dismutase in Drosophila melanogaster augments resistance of oxidative stress.

Authors:  I Reveillaud; A Niedzwiecki; K G Bensch; J E Fleming
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

8.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

9.  The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway.

Authors:  T Oltersdorf; P J Ward; T Henriksson; E C Beattie; R Neve; I Lieberburg; L C Fritz
Journal:  J Biol Chem       Date:  1990-03-15       Impact factor: 5.157

10.  Transplants of mouse trisomy 16 hippocampus provide a model of Alzheimer's disease neuropathology.

Authors:  S J Richards; J J Waters; K Beyreuther; C L Masters; C M Wischik; D R Sparkman; C L White; C R Abraham; S B Dunnett
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

View more
  17 in total

1.  Multiple autism-like behaviors in a novel transgenic mouse model.

Authors:  Shannon M Hamilton; Corinne M Spencer; Wilbur R Harrison; Lisa A Yuva-Paylor; Deanna F Graham; Ray A M Daza; Robert F Hevner; Paul A Overbeek; Richard Paylor
Journal:  Behav Brain Res       Date:  2010-11-17       Impact factor: 3.332

2.  Expression of neuronal-NOS in developing basal forebrain cholinergic neurons: regulation by NGF.

Authors:  D M Holtzman; S Lee; Y Li; J Chua-Couzens; H Xia; D S Bredt; W C Mobley
Journal:  Neurochem Res       Date:  1996-07       Impact factor: 3.996

3.  Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury.

Authors:  Y Cheng; M Deshmukh; A D'Costa; J A Demaro; J M Gidday; A Shah; Y Sun; M F Jacquin; E M Johnson; D M Holtzman
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

4.  Overexpression of esterase D in kidney from trisomy 13 fetuses.

Authors:  S Loughna; P Bennett; G Gau; K Nicolaides; S Blunt; G Moore
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

5.  Overexpression of a Shaker-type potassium channel in mammalian central nervous system dysregulates native potassium channel gene expression.

Authors:  M L Sutherland; S H Williams; R Abedi; P A Overbeek; P J Pfaffinger; J L Noebels
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

6.  Altered Ca2+ signaling and mitochondrial deficiencies in hippocampal neurons of trisomy 16 mice: a model of Down's syndrome.

Authors:  S Schuchmann; W Müller; U Heinemann
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

7.  Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain.

Authors:  B Brugg; Y L Dubreuil; G Huber; E E Wollman; N Delhaye-Bouchaud; J Mariani
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  Overexpression of liver-type phosphofructokinase (PFKL) in transgenic-PFKL mice: implication for gene dosage in trisomy 21.

Authors:  A Elson; D Levanon; Y Weiss; Y Groner
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

9.  Expression of TrkA confers neuron-like responsiveness to nerve growth factor on an immortalized hypothalamic cell line.

Authors:  J Zhou; D M Holtzman; R I Weiner; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Transgenic copper/zinc superoxide dismutase modulates susceptibility to type I diabetes.

Authors:  H M Kubisch; J Wang; R Luche; E Carlson; T M Bray; C J Epstein; J P Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.